These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 24552633)

  • 1. Associations between antipsychotics-induced weight gain and brain networks of impulsivity.
    Grosu C; Klauser P; Dwir D; Khadimallah I; Alemán-Gómez Y; Laaboub N; Piras M; Fournier M; Preisig M; Conus P; Draganski B; Eap CB
    Transl Psychiatry; 2024 Mar; 14(1):162. PubMed ID: 38531873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomic signatures associated with weight gain and psychosis spectrum diagnoses: A pilot study.
    Lee J; Costa-Dookhan K; Panganiban K; MacKenzie N; Treen QC; Chintoh A; Remington G; Müller DJ; Sockalingam S; Gerretsen P; Sanches M; Karnovsky A; Stringer KA; Ellingrod VL; Tso IF; Taylor SF; Agarwal SM; Hahn MK; Ward KM
    Front Psychiatry; 2023; 14():1169787. PubMed ID: 37168086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fat-mass and obesity-associated gene polymorphisms and weight gain after risperidone treatment in first episode schizophrenia.
    Song X; Pang L; Feng Y; Fan X; Li X; Zhang W; Gao J; Zhang J; Nemani K; Zhang H; Lv L
    Behav Brain Funct; 2014 Oct; 10(1):35. PubMed ID: 25278160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment resistant schizophrenia: a comprehensive survey of randomised controlled trials.
    Sinclair D; Adams CE
    BMC Psychiatry; 2014 Sep; 14():253. PubMed ID: 25227719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical applications of CYP genotyping in psychiatry.
    Spina E; de Leon J
    J Neural Transm (Vienna); 2015 Jan; 122(1):5-28. PubMed ID: 25200585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenomics in psychiatry: implications for practice.
    Moore TR; Hill AM; Panguluri SK
    Recent Pat Biotechnol; 2014; 8(2):152-9. PubMed ID: 25185985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Getting to precision psychopharmacology: Combining clinical and genetic information to predict fat gain from aripiprazole.
    Oughli H; Lenze EJ; Locke AE; Yingling MD; Zhong Y; Miller JP; Reynolds CF; Mulsant BH; Newcomer JW; Peterson TR; Müller DJ; Nicol GE
    J Psychiatr Res; 2019 Jul; 114():67-74. PubMed ID: 31039482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double jeopardy: a review of weight gain and weight management strategies for psychotropic medication prescribing during methadone maintenance treatment.
    Schlienz NJ; Huhn AS; Speed TJ; Sweeney MM; Antoine DG
    Int Rev Psychiatry; 2018 Oct; 30(5):147-154. PubMed ID: 30398080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unresolved Issues for Utilization of Atypical Antipsychotics in Schizophrenia: Antipsychotic Polypharmacy and Metabolic Syndrome.
    Jeon SW; Kim YK
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29057817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leptin and ghrelin levels in patients with schizophrenia during different antipsychotics treatment: a review.
    Sentissi O; Epelbaum J; Olié JP; Poirier MF
    Schizophr Bull; 2008 Nov; 34(6):1189-99. PubMed ID: 18165262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weight change with atypical antipsychotics in the treatment of schizophrenia.
    Haddad P
    J Psychopharmacol; 2005 Nov; 19(6 Suppl):16-27. PubMed ID: 16280334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of baseline body mass index and leptin serum level to the prediction of early weight gain with atypical antipsychotics in schizophrenia.
    Cortés B; Bécker J; Mories Álvarez MT; Marcos AI; Molina V
    Psychiatry Clin Neurosci; 2014 Feb; 68(2):127-32. PubMed ID: 24552633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trajectories of agouti-related protein and leptin levels during antipsychotic-associated weight gain in patients with schizophrenia.
    Ehrlich S; Leopold K; Merle JV; Theophil I; Haag W; Lautenschlager M; Schaefer M
    J Clin Psychopharmacol; 2012 Dec; 32(6):767-72. PubMed ID: 23131879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia.
    Popovic V; Doknic M; Maric N; Pekic S; Damjanovic A; Miljic D; Popovic S; Miljic N; Djurovic M; Jasovic-Gasic M; Dieguez C; Casanueva FF
    Neuroendocrinology; 2007; 85(4):249-56. PubMed ID: 17570902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of second generation antipsychotics on leptin and ghrelin.
    Esen-Danaci A; Sarandöl A; Taneli F; Yurtsever F; Ozlen N
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1434-8. PubMed ID: 18579280
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.